Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Biofrontera Inc.

Biofrontera Inc. (BFRI) Stock Overview

Explore Biofrontera Inc.’s financial performance, market position, analyst ratings, and future outlook.

BFRI●NASDAQ
HealthcareMedical - Pharmaceuticals
$1.48
$0.00(0.00%)
U.S. Market opens in 52h 37m

Biofrontera Inc. (BFRI)

Meyka AI Score

Z

Key Financials

Market Cap18.9M
P/E Ratio-2.47
EPS (TTM)$-0.55
ROE-1.28%
Fundamental Analysis

AI Price Forecasts

1 Month$1.33
3 Months$1.20
1 Year Target$16.98

BFRI Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Biofrontera Inc. (NASDAQ: BFRI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Biofrontera Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BFRI on the NASDAQ shows an RSI of 75.72, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $16.98 for the NASDAQ listing.

Key metrics behind Biofrontera Inc.'s NASDAQ-traded stock include a P/E ratio of -2.47 and a market capitalization of 18.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BFRI on the NASDAQ.

Price Performance (NASDAQ: BFRI)

1-Day Change
N/A
5-Day Change
15.63%
1-Month Change
37.04%
3-Month Change
89.94%
6-Month Change
67.10%
Year-to-Date (YTD) Change
159.65%
1-Year Change
69.008%
3-Year Change
-83.18%
5-Year Change
-98.32%
All-Time (Max) Change
-98.32%

Contact Information

https://www.biofrontera-us.com
781 245 1325
660 Main Street, Woburn, MA, 01801

Company Facts

890 Employees
IPO DateOct 29, 2021
CountryUS
Actively Trading

Frequently Asked Questions